Arkolith/Insider Trading/NAVB/Form 4

Bhalla Amit

DirectorNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed Dec 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 30, 2021Grant(A)1K—$043K
Nov 15, 2021Grant(A)3K—$042K
Nov 15, 2021Grant(A)30K—$039K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-21-027690) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML